{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T07:19:53Z","timestamp":1768288793026,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Natural Science Foundation of Yichang","award":["81300626"],"award-info":[{"award-number":["81300626"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Primary urethral cancer is exceedingly rare, resulting in a limitation in clinicians\u2019 experience, and an accurate diagnosis is often delayed due to the non-specific clinical presentation. Here, we present this case report to show the treatment of a patient with primary urethral cancer. Our patient was diagnosed as having primary urethral cancer in the First Clinical Hospital of Yichang by cystoscopy and biopsy. Due to her age, poor physical tolerance, and economic condition, she refused radical operation. Since there is no definite guideline for the treatment process of primary urethral cancer in clinics, operation methods and postoperative adjuvant treatments vary in different hospitals, leading to diverse prognostic effects.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>An 88-year-old Asian woman had difficulty in urinating for more than 6 months and the syndrome was aggravated for 1 month. She chose a relatively conservative treatment plan: primary tumor resection combined with bladder perfusion chemotherapy. Postoperative pathology revealed \u201curethra\u201d high-grade urothelial carcinoma (sarcoma-like variants) with extensive necrosis. After treatment with intravesical chemotherapeutic drug (hydroxycamptothecin 40\u2009mg), she was eventually released from our hospital in a stable condition. Postoperation follow-up was performed to observe to what extent this conservative treatment plan improved the quality of life and overall survival time of our patient.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>She needed radical resection according to the actual situation. However, her age restricted her tolerance to general anesthesia; relatively conservative treatment options are available to ensure a high quality of life. The treatment of primary tumor resection combined with bladder perfusion chemotherapy is feasible. This case highlights the importance of the dissemination of new cases and optimizing primary urethral cancer diagnosis to obtain an effective treatment.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13256-019-2253-y","type":"journal-article","created":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T01:02:41Z","timestamp":1574989361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Advanced primary urethral cancer: a case report"],"prefix":"10.1186","volume":"13","author":[{"given":"Huan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li Li","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan Jiang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi Qiang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,29]]},"reference":[{"issue":"5","key":"2253_CR1","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.eururo.2013.03.044","volume":"64","author":"G Gakis","year":"2013","unstructured":"Gakis G, Witjes JA, Comperat E, et al. EAU guidelines on primary urethral carcinoma. Eur Urol. 2013;64(5):823\u201330.","journal-title":"Eur Urol"},{"issue":"19","key":"2253_CR2","doi-asserted-by":"publisher","first-page":"e3642","DOI":"10.1097\/MD.0000000000003642","volume":"95","author":"G Lucarelli","year":"2016","unstructured":"Lucarelli G, Spilotros M, Vavallo A, et al. A Challenging Surgical Approach to Locally Advanced Primary Urethral Carcinoma: A Case Report and Literature Review. Medicine. 2016;95(19):e3642.","journal-title":"Medicine"},{"issue":"4","key":"2253_CR3","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s11255-017-1512-3","volume":"49","author":"RH Berjeaut","year":"2017","unstructured":"Berjeaut RH, Persaud MD, Sopko N, et al. Urethral carcinoma in situ: recognition and management. Int Urol Nephrol. 2017;49(4):637\u201341.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"2253_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00345-015-1583-7","volume":"34","author":"G Gakis","year":"2016","unstructured":"Gakis G, Morgan TM, Efstathiou JA, et al. Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma. World J Urol. 2016;34(1):97\u2013103.","journal-title":"World J Urol"},{"key":"2253_CR5","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.urology.2016.09.042","volume":"100","author":"W Sui","year":"2017","unstructured":"Sui W, RoyChoudhury A, Wenske S, et al. Outcomes and Prognostic Factors of Primary Urethral Cancer. Urology. 2017;100:180\u20136.","journal-title":"Urology"},{"issue":"6","key":"2253_CR6","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1016\/j.juro.2010.02.016","volume":"183","author":"DE Chung","year":"2010","unstructured":"Chung DE, Purohit RS, Girshman J, et al. Urethral diverticula in women: discrepancies between magnetic resonance imaging and surgical findings. J Urol. 2010;183(6):2265\u20139.","journal-title":"J Urol"},{"issue":"4","key":"2253_CR7","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ejca.2011.10.031","volume":"48","author":"O Visser","year":"2012","unstructured":"Visser O, Adolfsson J, Rossi S, et al. Incidence and survival of rare urogenital cancers in Europe. Eur J Cancer (Oxford, England : 1990). 2012;48(4):456\u201364.","journal-title":"Eur J Cancer (Oxford, England : 1990)"},{"issue":"6","key":"2253_CR8","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.urology.2006.08.1057","volume":"68","author":"MA Swartz","year":"2006","unstructured":"Swartz MA, Porter MP, Lin DW, et al. Incidence of primary urethral carcinoma in the United States. Urology. 2006;68(6):1164\u20138.","journal-title":"Urology"},{"issue":"11","key":"2253_CR9","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1002\/cncr.25787","volume":"117","author":"F Rabbani","year":"2011","unstructured":"Rabbani F. Prognostic factors in male urethral cancer. Cancer. 2011;117(11):2426\u201334.","journal-title":"Cancer"},{"issue":"1","key":"2253_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00345-012-0882-5","volume":"31","author":"JW Derksen","year":"2013","unstructured":"Derksen JW, Visser O, de la Riviere GB, et al. Primary urethral carcinoma in females: an epidemiologic study on demographical factors, histological types, tumour stage and survival. World J Urol. 2013;31(1):147\u201353.","journal-title":"World J Urol"},{"issue":"4","key":"2253_CR11","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ucl.2016.06.011","volume":"43","author":"LN Zinman","year":"2016","unstructured":"Zinman LN, Vanni AJ. Management of Proximal Primary Urethral Cancer: Should Multidisciplinary Therapy Be the Gold Standard? Urol Clin North Am. 2016;43(4):505\u201313.","journal-title":"Urol Clin North Am"},{"issue":"2","key":"2253_CR12","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.juro.2014.07.105","volume":"193","author":"M Kent","year":"2015","unstructured":"Kent M, Zinman L, Girshovich L, et al. Combined chemoradiation as primary treatment for invasive male urethral cancer. J Urol. 2015;193(2):532\u20137.","journal-title":"J Urol"},{"issue":"6","key":"2253_CR13","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1046\/j.1464-410X.1998.00878.x","volume":"82","author":"G Dalbagni","year":"1998","unstructured":"Dalbagni G, Zhang ZF, Lacombe L, et al. Female urethral carcinoma: an analysis of treatment outcome and a plea for a standardized management strategy. Br J Urol. 1998;82(6):835\u201341.","journal-title":"Br J Urol"},{"issue":"1","key":"2253_CR14","doi-asserted-by":"publisher","first-page":"10.e17","DOI":"10.1016\/j.urolonc.2017.09.012","volume":"36","author":"G Gakis","year":"2018","unstructured":"Gakis G, Schubert T, Morgan TM, et al. The prognostic effect of salvage surgery and radiotherapy in patients with recurrent primary urethral carcinoma. Urol Oncol. 2018;36(1):10.e17\u20134.","journal-title":"Urol Oncol"},{"issue":"5","key":"2253_CR15","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.eururo.2005.12.019","volume":"49","author":"J Palou Redorta","year":"2006","unstructured":"Palou Redorta J, Schatteman P, Huguet Perez J, et al. Intravesical instillations with bacillus calmette-guerin for the treatment of carcinoma in situ involving prostatic ducts. Eur Urol. 2006;49(5):834\u20138. discussion 838","journal-title":"Eur Urol"},{"issue":"6","key":"2253_CR16","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3816\/CGC.2007.n.021","volume":"5","author":"JH Taylor","year":"2007","unstructured":"Taylor JH, Davis J, Schellhammer P. Long-term follow-up of intravesical bacillus Calmette-Guerin treatment for superficial transitional-cell carcinoma of the bladder involving the prostatic urethra. Clin Genitourin Cancer. 2007;5(6):386\u20139.","journal-title":"Clin Genitourin Cancer"},{"issue":"5","key":"2253_CR17","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1097\/01.ju.0000121604.58067.95","volume":"171","author":"A Vazina","year":"2004","unstructured":"Vazina A, Dugi D, Shariat SF, et al. Stage specific lymph node metastasis mapping in radical cystectomy specimens. J Urol. 2004;171(5):1830\u20134.","journal-title":"J Urol"},{"issue":"4","key":"2253_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1365-2303.2010.00791.x","volume":"22","author":"H Ohsaki","year":"2011","unstructured":"Ohsaki H, Hirakawa E, Nakamura M, et al. Expression of vimentin and high-molecular-weight cytokeratin (clone 34\u00dfE12) in differentiating reactive renal tubular cells from low-grade urothelial carcinoma cells in voided urine. Cytopathology. 2011;22(4):247\u201352.","journal-title":"Cytopathology"},{"issue":"9","key":"2253_CR19","first-page":"1372","volume":"33","author":"Y Li","year":"2013","unstructured":"Li Y, Liu H, Du X, et al. Expression of Engrailed-2 and \u03b2-catenin in bladder urothelial carcinoma and their significance. Nan Fang Yi Ke Da Xue Xue Bao = J South Med Univ. 2013;33(9):1372.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao = J South Med Univ"},{"issue":"4","key":"2253_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.17305\/bjbms.2015.556","volume":"15","author":"S Senol","year":"2015","unstructured":"Senol S, Yildirim A, Ceyran B, et al. Prognostic significance of survivin, \u03b2-catenin and p53 expression in urothelial carcinoma. Bosn J Basic Med Sci. 2015;15(4):7\u201314.","journal-title":"Bosn J Basic Med Sci"},{"issue":"1","key":"2253_CR21","first-page":"400","volume":"30","author":"A Mojgan","year":"2016","unstructured":"Mojgan A, Mahtab NM, Maryam A. Differential diagnosis of urothelial carcinoma in situ from non-neoplastic urothelia: Analysis of CK20, CD44, P53 and Ki67. Med J Islam Repub Iran. 2016;30(1):400.","journal-title":"Med J Islam Repub Iran"},{"issue":"3","key":"2253_CR22","first-page":"227","volume":"39","author":"MA Mka","year":"2017","unstructured":"Mka MA, Hussin H, Veerakumarasivam A, et al. Immunohistochemical expression of NANOG in urothelial carcinoma of the bladder. Malays J Pathol. 2017;39(3):227\u201334.","journal-title":"Malays J Pathol"},{"issue":"10","key":"2253_CR23","doi-asserted-by":"publisher","first-page":"432.e439","DOI":"10.1016\/j.urolonc.2016.04.016","volume":"34","author":"KH Mohammed","year":"2016","unstructured":"Mohammed KH, Siddiqui MT, Cohen C. GATA3 immunohistochemical expression in invasive urothelial carcinoma. Urol Oncol. 2016;34(10):432.e439\u201313.","journal-title":"Urol Oncol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-019-2253-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-019-2253-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-019-2253-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T00:10:58Z","timestamp":1606522258000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-019-2253-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,29]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2253"],"URL":"https:\/\/doi.org\/10.1186\/s13256-019-2253-y","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,29]]},"assertion":[{"value":"31 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"365"}}